Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human EEF2 Anticorps:
anti-Mouse (Murine) EEF2 Anticorps:
anti-Rat (Rattus) EEF2 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal EEF2 Primary Antibody pour ICC, IHC - ABIN969090
Maggi, Kuchenruether, Dadey, Schwope, Grisendi, Townsend, Pandolfi, Weber: Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. dans Molecular and cellular biology 2008
Show all 2 Pubmed References
Human Monoclonal EEF2 Primary Antibody pour IF, ELISA - ABIN966028
Rose, Bisiani, Vistisen, Kiens, Richter: Skeletal muscle eEF2 and 4EBP1 phosphorylation during endurance exercise is dependent on intensity and muscle fiber type. dans American journal of physiology. Regulatory, integrative and comparative physiology 2009
Show all 2 Pubmed References
the direct interaction of AKT2 (Montrer AKT2 Anticorps) and EF2 was found to be dynamically regulated in embryonic rat cardiomyocytes
These results suggest that binding of eEF2 to the ribosome alters its conformation, resulting in a weakened affinity of eIF5A (Montrer EIF5 Anticorps) and impairment of this interplay compromises cell growth due to translation elongation defects.
nuclear localization of active eEF-2 depends upon its interaction with p53 (Montrer TP53 Anticorps), as cells lacking p53 (Montrer TP53 Anticorps) contain less active eEF-2 in the nuclear compartment
High serum eukaryotic elongation factor 2 level is associated with non-small cell lung cancer.
Results indicated that the eEF2 gene is overexpressed in the majority of several types of cancers and plays an oncogenic role in cancer cell growth.
The expression levels of three putative HA-regulated proteins (TALDO, ANXA1 (Montrer ANXA1 Anticorps) and EF2) in control, H2O2-, HA- and HA/H2O2-treated OA chondrocytes were verified by Western blotting and the results indeed support the notion that HA acts in anti-oxidation
Data indicate that the accumulation of the cleaved C-terminal small fragment of eukaryotic elongation factor 2 (eEF2) in the nucleus, and C-terminal Src kinase (Csk (Montrer CSK Anticorps)) could enhance the proteolytic cleavage of eEF2.
Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
A single amino acid substitution in eukaryotic elongation factor 2 co-segregates with the disease phenotype of spinocerebellar ataxia 26.
EEF2 phosphorylation by cyclin A (Montrer CCNA2 Anticorps)-cyclin-dependent kinase 2 (CDK2 (Montrer CDK2 Anticorps)) on a novel site, serine 595 (S595), directly regulates T56 phosphorylation by eEF2K (Montrer EEF2K Anticorps).
Myostatin (Montrer MSTN Anticorps) inhibits eEF2K (Montrer EEF2K Anticorps)-eEF2 by regulating AMPK (Montrer PRKAA1 Anticorps) to suppress protein synthesis.
IL-6 (Montrer IL6 Anticorps) induces the activation of the Stat3 (Montrer STAT3 Anticorps) signaling and promotes the downmodulation of the p90RSK (Montrer RPS6KA1 Anticorps)/eEF2 and mTOR (Montrer FRAP1 Anticorps)/p70S6K (Montrer RPS6KB1 Anticorps) axes, while it does not affect the activation of AKT (Montrer AKT1 Anticorps).
AMPKalpha2 (Montrer PRKAA2 Anticorps) controls cardiac p70S6K (Montrer RPS6KB1 Anticorps) under normoxia and regulates eEF-2 but not the mTOR (Montrer FRAP1 Anticorps)-p70S6K (Montrer RPS6KB1 Anticorps) pathway during ischemia.
The MKK3 (Montrer MAP2K3 Anticorps)/6-p38gamma (Montrer MAPK12 Anticorps)/delta pathway mediated an inhibitory phosphorylation of eukaryotic elongation factor 2 (eEF2) kinase, which in turn promoted eEF2 activation (dephosphorylation) and subsequent TNF-alpha (Montrer TNF Anticorps) elongation.
Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development
induced by basic fibroblast growth factor (Montrer FGF2 Anticorps) via mitogen-activated protein kinase (Montrer MAPK1 Anticorps)
eEF-2 is activated by both lithium and GSK-3, whereas, lithium treatment and inhibition of GSK-3 have opposing effects on eEF-2.
eEF-2 phosphorylation has a role in protein synthesis for memory consolidation
A mouse that was mutant for the gene, Dph4 (Montrer DNAJC24 Anticorps), was identified.
Eukaryotic elongation factor-2 (eEF2) may be a limiting factor in milk protein (Montrer CSN2 Anticorps) synthesis (Review)
EF-2 is a developmentally regulated gene and might play important roles during the early development of zebrafish embryos.
Whole mount in situ hybridization on zebrafish embryos shows that the transcripts of EF-2 gene are detected during the early development of zebrafish embryo and constantly change from 5-somite stage to protruding-mouth stage.
This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation.
elongation factor 2
, polypeptidyl-tRNA translocase
, elongation factor-2
, eukaryotic translation elongation factor 2
, elongation factor 2-like
, eukaryotic translation elongation factor 2, like
, ETS-related factor2
, LOW QUALITY PROTEIN: elongation factor 2
, CG2238 gene product from transcript CG2238-RD
, ELONGATION FACTOR 2
, elongation factor 2b
, eukaryotic translation elongation factor 2b